EMCDDA, Nigel Hawtin, Lisbon, April 2020
Summary
Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the world in which we live. By complementing data routinely submitted by Member States with information from an expanding range of leading-edge sources shown below, the agency can now respond with more timely and rounded analyses to inform drug policies and practice in the years to come. This graphic was produced to mark the EMCDDA’s 25 years of monitoring milestone. Additinal information may be found on the accompanying news item.
Main subject:
Follow this news feed: EU